Tandem Diabetes Care (NASDAQ:TNDM) Hits New 12-Month Low on Analyst Downgrade
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) shares reached a new 52-week low on Thursday after Royal Bank of Canada lowered their price target on the stock from $65.00 to $55.00. Royal Bank of Canada currently has an outperform rating on the stock. Tandem Diabetes Care traded as low as $25.50 and last […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) shares reached a new 52-week low on Thursday after Royal Bank of Canada lowered their price target on the stock from $65.00 to $55.00. Royal Bank of Canada currently has an outperform rating on the stock. Tandem Diabetes Care traded as low as $25.50 and last […]
